AGP Executive Report
Last update: 10 hours agoHemp Rules: U.S. federal changes due Dec. 11 will cap total THC in hemp-derived products at 0.4 milligrams per container, putting many CBD and other cannabinoid goods at risk. THC-free products may have the clearest path to market. Medical Cannabis Access: Nebraska’s first licensed grower is weeks from harvest, but it has no route to lab testing, manufacturing or transport, leaving patients waiting despite voter approval two years ago. Sleep Research: A Cochrane review of nine trials involving 537 adults found little to no meaningful sleep benefit from medical cannabis versus placebo. Researchers caution that the studies were small and varied, so the findings are not conclusive. Pet Safety: Products made for people can harm dogs and cats. CBD-labeled items may contain THC, while gummies can include toxic ingredients such as xylitol; owners should keep them out of reach.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
